Top compounds associated with response to THNSL2


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.014 0.7
mRNA AZ628 GDSC1000 pan-cancer AAC 0.02 0.7
mRNA BMS-754807 GDSC1000 pan-cancer AAC 0.013 0.7
mRNA masitinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA BRD-K20514654 CTRPv2 pan-cancer AAC 0.02 0.7
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC 0.018 0.7
mRNA clofarabine CTRPv2 pan-cancer AAC -0.011 0.7
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.021 0.7
mRNA Bortezomib FIMM pan-cancer AAC -0.065 0.7
mRNA BRD1812 CTRPv2 pan-cancer AAC 0.013 0.7
Download CSV